Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 666-671, January 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kraupp-Grasl, B.
Right arrow Articles by Schulte-Hermann, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kraupp-Grasl, B.
Right arrow Articles by Schulte-Hermann, R.

Increased Susceptibility of Aged Rats to Hepatocarcinogenesis by the Peroxisome Proliferator Nafenopin and the Possible Involvement of Altered Liver Foci Occurring Spontaneously

Bettina Kraupp-Grasl, Wolfgang Huber, Henrik Taper and Rolf Schulte-Hermann1

Institut für Tumorbiologie-Krebsforschung, Universität Wien, Borschkegasse 8a, 1090 Vienna, Austria [B. K-G., W. H., R. S-H.], and Unité de Biochimie Toxicologique et Cancerologique, Université Catholique de Louvain, UCL 7369, 1200 Brussels, Belgium [H. T.]

We investigated the mechanism of the hepatocarcinogenic action of nafenopin (NAF), a nongenotoxic peroxisome proliferator. Groups of male rats aged 13 wk (designated "young") or 57 wk (designated "old") were fed NAF for 13 mo; additional groups received a basal diet or a phenobarbital (PB)-containing diet as positive control.

The following results were obtained. (a) NAF produced numerous hepatocellular adenomas and carcinomas in old animals but very few in young animals. A similar result, although less pronounced, was seen with PB. Adenomas of PB-treated groups mostly consisted of eosinophilic and glycogen-storing cells. However, adenomas and carcinomas of NAF-treated livers were composed of weakly basophilic cells. (b) Phenotypically altered foci, evaluated in hematoxylin:eosin-stained sections, appeared spontaneously in untreated livers. The majority of these foci was either of the eosinophilic-clear cell or the tigroid cell type. In addition, we identified foci which are characterized by weak, diffuse cytoplasmatic basophilia. Their phenotype was similar to that of adenomas and carcinomas in NAF-treated rats. The number and size of eosinophilic-clear cell and of tigroid cell foci increased considerably with the age of the animals. At the end of the experiment, approximately 2.4% of liver tissue was occupied by focal cells. NAF, but not PB, treatment led to a selective increase in number and size of weakly basophilic foci. This subtype has previously been described as a likely precursor lesion for liver tumors induced by an aflatoxin B1-NAF initiation-promotion regimen (B. Kraupp-Grasl et al., Cancer Res., 50: 3701–3708, 1990).

These findings suggest that the peroxisome proliferator NAF leads to tumor development in aging rat liver by promotion of spontaneously occurring preneoplastic lesions. The type of lesion appears to be different from that promotable by PB.

1 To whom requests for reprints should be addressed.

Received 5/24/90. Accepted 10/29/90.




This article has been cited by other articles:


Home page
Toxicol SciHome page
C. Michel, C. Desdouets, M. Slaoui, K. R. Isaacs, R. A. Roberts, and E. Boitier
Diethylnitrosamine Initiation Does Not Alter Clofibric Acid Induced Hepatocarcinogenesis in the Rat
Toxicol. Sci., September 1, 2007; 99(1): 58 - 69.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
W. Bursch, M. Chabicovsky, U. Wastl, B. Grasl-Kraupp, K. Bukowska, H. Taper, and R. Schulte-Hermann
Apoptosis in Stages of Mouse Hepatocarcinogenesis: Failure to Counterbalance Cell Proliferation and to Account for Strain Differences in Tumor Susceptibility
Toxicol. Sci., May 1, 2005; 85(1): 515 - 529.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
M. M. Elrick, J. A. Kramer, C. L. Alden, E. A. G. Blomme, R. T. Bunch, M. A. Cabonce, S. W. Curtiss, L. D. Kier, K. L. Kolaja, C. P. Rodi, et al.
Differential Display in Rat Livers Treated for 13 Weeks with Phenobarbital Implicates a Role for Metabolic and Oxidative Stress in Nongenotoxic Carcinogenicity
Toxicol Pathol, January 1, 2005; 33(1): 118 - 126.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Rusyn, S. Yamashina, B. H. Segal, R. Schoonhoven, S. M. Holland, R. C. Cattley, J. A. Swenberg, and R. G. Thurman
Oxidants from Nicotinamide Adenine Dinucleotide Phosphate Oxidase Are Involved in Triggering Cell Proliferation in the Liver Due to Peroxisome Proliferators
Cancer Res., September 1, 2000; 60(17): 4798 - 4803.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
I. G. Shabalina, T. Panaretakis, A. Bergstrand, and J. W. Depierre
Effects of the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid, on apoptosis in human hepatoma HepG2 cells
Carcinogenesis, December 1, 1999; 20(12): 2237 - 2246.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. L. Rose, R. C. Cattley, C. Dunn, V. Wong, X. Li, and R. G. Thurman
Dietary glycine prevents the development of liver tumors caused by the peroxisome proliferator WY-14,643
Carcinogenesis, November 1, 1999; 20(11): 2075 - 2081.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. L. Rokos and B. J. Ledwith
Peroxisome Proliferators Activate Extracellular Signal-regulated Kinases in Immortalized Mouse Liver Cells
J. Biol. Chem., May 16, 1997; 272(20): 13452 - 13457.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.